Efficacy of faricimab secondary to anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a systematic review and meta-analysis.

چکیده

This study examines the efficacy and safety of faricimab as a secondary treatment for neovascular age-related macular degeneration (nAMD) patients previously treated with anti-vascular endothelial growth factors (anti-VEGF) agents. A literature search was performed on PubMed, EMBASE, and Cochrane…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• تصویربرداری و تشخیص
• درمان های ضد VEGF
• دژنراسیون ماکولا